The Scientific Integrity Act would amend the America COMPETES Act to require federal agencies that fund, conduct, or oversee scientific research to adopt, enforce, and publicly post scientific integrity policies. Those policies must prohibit misconduct such as fraud, suppression or alteration of findings, coercion to censor scientific results, and institutional barriers to cooperation with outside scientists. The bill also protects scientists’ ability to publish, present, and participate in the broader scientific community, while allowing agencies to require technical review before public dissemination if the review process is clear and consistent.
The bill further requires each covered agency to appoint a Scientific Integrity Officer, establish administrative complaint and appeal procedures, provide regular training, and issue annual public reports on complaints and outcomes. It also directs the Office of Science and Technology Policy to collect agency reports, share them publicly, and convene agency integrity কর্মকর্তাদের annually. Existing agency policies can satisfy the new requirements if formally determined to do so and approved by OSTP, and the bill clarifies that it does not affect copyright law.
The bill would create a government-wide framework for scientific integrity across federal agencies involved in research, affecting agency policies, personnel practices, reporting obligations, and oversight by OSTP. It would amend section 1009 of the America COMPETES Act and define covered agencies and covered individuals broadly enough to include employees and contractors engaged in scientific work, those communicating scientific results, and those using science in policy or regulatory decisions. The measure would also require periodic review by agencies, OSTP approval of substantial changes, and a Comptroller General review after two years, increasing federal accountability and transparency around scientific research and its communication.
The bill’s text reflects strong support for protecting science from political interference, and the sponsor list suggests a broad coalition of Democratic senators backing the measure. The stated purpose is to strengthen public trust in science, safeguard whistleblowers and researchers, and ensure that scientific findings are communicated openly and accurately. No committee transcript or vote data is provided, so there is no recorded opposition or amendment debate in the supplied materials.
The main potential points of contention are the bill’s limits on agency control over scientific communication and its requirement that policies be approved by OSTP, which could be viewed as either necessary oversight or as adding another layer of federal review. Agencies may also have concerns about how technical review before publication is implemented, how broad the definition of covered individuals is, and how whistleblower and appeal procedures interact with existing personnel rules. Because no hearing transcript or vote history is included, specific objections from lawmakers, agencies, or stakeholders are not documented in the provided record.